DrugPatentWatch Database Preview
Patent: 5,545,405
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Patent: 5,545,405
| Title: | Method for treating a mammal suffering from cancer with a cho-glycosylated antibody |
| Abstract: | The invention relates to a CHO cell-line capable of producing antibody, the cell-line having been co-transfected with a vector capable of expressing the light chain of the antibody and a vector capable of expressing the heavy chain of the antibody wherein the vectors contain independently selectable markers; also included is a CHO cell-line capable of producing a human antibody or an altered antibody, the cell-line having been transfected with a vector capable of expressing the light chain of the antibody and the heavy chain of the antibody; process for the production of antibody using a CHO cell-line and antibody having CHO glycosylation. |
| Inventor(s): | Page; Martin J. (Beckenham, GB) |
| Assignee: | Burroughs Wellcome Co. (Research Triangle Park, NC) |
| Application Number: | 08/335,401 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,545,405
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme | LEMTRADA | alemtuzumab | INJECTABLE;INJECTION | 103948 | 003 | 2001-05-07 | Start Trial | Burroughs Wellcome Co. (Research Triangle Park, NC) | 2013-08-13 | RX | Orphan | company |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 002 | 2001-05-07 | Start Trial | Burroughs Wellcome Co. (Research Triangle Park, NC) | 2013-08-13 | RX | Orphan | company |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | Start Trial | Burroughs Wellcome Co. (Research Triangle Park, NC) | 2013-08-13 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 5,545,405
| Country | Patent Number | Publication Date |
|---|---|---|
| South Africa | 9108248 | Apr 16, 1993 |
| United States of America | 2002182208 | Dec 05, 2002 |
| United States of America | 2003035799 | Feb 20, 2003 |
| United States of America | 2004228857 | Nov 18, 2004 |
| United States of America | 2008279852 | Nov 13, 2008 |
| United States of America | 5545403 | Aug 13, 1996 |
| United States of America | 5545404 | Aug 13, 1996 |
| >Country | >Patent Number | >Publication Date |
